Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of: November 2024

 

Commission file number: 001-41557

 

CLEARMIND MEDICINE INC.

(Translation of registrant’s name into English)

 

101 – 1220 West 6th Avenue

Vancouver, British Columbia

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒        Form 40-F ☐

 

 

 

 

 

 

CONTENTS

 

On November 20, 2024, Clearmind Medicine Inc. (the “Company”) published a notice (the “Notice”) that it will hold an Annual and Special Meeting of Shareholders on January 6, 2025, with a record date (the “Record Date”) on November 28, 2024. After the Record Date, the Company will distribute the proxy materials (which will include the full version of the proposed resolutions) and a proxy card to all shareholders of record as of the Record Date. The Notice is furnished as Exhibit 99.1 herewith.

 

This 6-K incorporated by reference into the Registrant’s Registration Statements on Form F-3 (File No. 333-275991, 333-270859, 333-273293), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

1

 

 

EXHIBIT INDEX

 

Exhibit No.
99.1		Notice of Annual and Special Meeting of Shareholders of Clearmind Medicine Inc. to be held on January 6, 2024.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	Clearmind Medicine, Inc.
	(Registrant)
Date: November 20, 2024	By:	/s/ Adi Zuloff-Shani
	Name:	Adi Zuloff-Shani
	Title:	Chief Executive Officer

 

3

 

Exhibit 99.1

 

November 20, 2024		510 Burrard St, 3rd Floor
		Vancouver BC, V6C 3B9
		www.computershare.com

 

To:	All Canadian Securities Regulatory Authorities
	NASDAQ Exchange

 

Subject: CLEARMIND MEDICINE INC. 

 

Dear Sir/Madam:

 

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: 

 

Meeting Type :	Annual and Special Meeting
Record Date for Notice of Meeting :	November 28, 2024
Record Date for Voting (if applicable) :	November 28, 2024
Beneficial Ownership Determination Date :	November 28, 2024
Meeting Date :	January 06, 2025
Meeting Location (if available) :	Virtual Meeting
Issuer sending proxy related materials directly to NOBO:	Yes
Issuer paying for delivery to OBO:	No
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders	No
NAA for Registered Holders	No

 

Voting Security Details:
Description		CUSIP Number		ISIN
COMMON CLASS		185053402		CA1850534027

 

Sincerely,

 

Computershare

Agent for CLEARMIND MEDICINE INC. 

---